Market Overview:
The global T-shaped intrauterine device market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing awareness about contraception, rising prevalence of sexually transmitted infections (STIs), and growing demand for long-term reversible contraception methods. Based on type, the hormonal IUD segment is expected to account for the largest share of the global T-shaped intrauterine device market in 2018. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to factors such as increasing preference for long-term reversible contraception methods and rising incidence of STIs. Based on application, age 20-24 segment is expected to account for the largest share of the global T-shaped intrauterine device market in 2018.
Product Definition:
A T-shaped intrauterine device (IUD) is a type of long-acting reversible contraception. It is inserted into the uterus by a healthcare professional to prevent pregnancy.
Hormonal IUD:
Hormonal IUD, also called T-shaped Intrauterine Device (T-IUD), is a type of birth control that works by preventing pregnancy. It’s a small device made up of flexible plastic or metal that is inserted into the uterus and then releases slowly over an average period of three to four months. Hormonal IUDs are most effective when used in combination with another method of contraception such as the pill, condom, or diaphragm.
Copper IUD:
Copper IUD is a small device made up of thin copper wire which is inserted into the uterus through the cervix. It works by creating an electrical field around the fetus and prevents implantation of fertilized egg in the uterus. The device works for both oral as well as injectable contraceptive methods.
The product was approved by FDA in 2000.
Application Insights:
The others application segment includes age groups of 15-19, 20-24 and 45+. The demand for the hormonal IUD is highest among women aged 35-44. This can be attributed to high usage rates observed among this demographic group. Moreover, increasing awareness about the benefits associated with long term use of hormonal IUDs is expected to drive growth over the forecast period.
Copper T shaped intrauterine device was most commonly used in other applications segment owing to its ability to provide extended protection against pregnancy with reduced side effects as compared to other devices such as hormone based IUDs and LNGIUS. Increasing adoption of copper T shaped devices in North America and Europe due to rising awareness regarding their advantages over other methods such as sterilization procedures conducted by doctors are likely fuel market growth during the forecast period 2018 ¢â‚¬â€œ 2030.
Regional Analysis:
Europe dominated the global market in 2017. The presence of well-established healthcare infrastructure, high awareness levels regarding contraception, and demand for highly effective methods are some of the major factors responsible for its dominance. Moreover, an increase in government initiatives to provide access to modern contraceptive devices is expected to boost growth over the forecast period. For instance, Bilateral T-shaped IUD (Mirena) was approved by European Medicines Agency (EMA) in November 2015 and it was launched commercially later that year.
In Asia Pacific region, China held a significant share owing to high unmet contraceptive needs among its population and rapid urbanization coupled with increasing disposable income resulting into rising number of sexual encounters among them teenagers & adults which increases their risk of pregnancy also creating a potential market opportunity over the next eight years.
Growth Factors:
- Increasing awareness about the benefits of using T-shaped Intrauterine Device: There is a growing awareness among women about the benefits of using T-shaped Intrauterine Device, which is helping to drive its growth.
- Rising demand for minimally invasive procedures: The demand for minimally invasive procedures is rising, as they are less risky and cause less pain and discomfort than traditional surgery. This is benefiting the T-shaped Intrauterine Device market as well.
- Growing number of product launches: The number of product launches in the T-shaped Intrauterine Device market is increasing as manufacturers are focusing on expanding their offerings to cater to the needs of different customer segments. This is helping to fuel market growth.
- Increasing adoption by developed countries: Developed countries are increasingly adopting T-shaped Intrauterine Devices owing to their many advantages over traditional methods such as sterilization or hysterectomy surgeries .This is propelling market growth significantly . 5) Technological advancements : Technological advancements in manufacturing processes and design are resulting in better quality products with enhanced features being launched in the market, thereby fuelling adoption rates
Scope Of The Report
Report Attributes
Report Details
Report Title
T-shaped Intrauterine Device Market Research Report
By Type
Hormonal IUD, Copper IUD
By Application
Age 20-24, Age 25-34, Age 35-44, Others
By Companies
Bayer, Merck, Teva Pharmaceutical, Allergan, HRA Pharma, Eurogine, Yantai JiShengYaoXie, TianYi, SMB Corporation, Shenyang Liren, H & J Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global T-shaped Intrauterine Device Market Report Segments:
The global T-shaped Intrauterine Device market is segmented on the basis of:
Types
Hormonal IUD, Copper IUD
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Age 20-24, Age 25-34, Age 35-44, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Merck
- Teva Pharmaceutical
- Allergan
- HRA Pharma
- Eurogine
- Yantai JiShengYaoXie
- TianYi
- SMB Corporation
- Shenyang Liren
- H & J Medical
Highlights of The T-shaped Intrauterine Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hormonal IUD
- Copper IUD
- By Application:
- Age 20-24
- Age 25-34
- Age 35-44
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the T-shaped Intrauterine Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A T-shaped intrauterine device (IUD) is a type of birth control that is inserted into the uterus by a doctor. It works by preventing sperm from reaching the egg.
Some of the key players operating in the t-shaped intrauterine device market are Bayer, Merck, Teva Pharmaceutical, Allergan, HRA Pharma, Eurogine, Yantai JiShengYaoXie, TianYi, SMB Corporation, Shenyang Liren, H & J Medical.
The t-shaped intrauterine device market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 T-shaped Intrauterine Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 T-shaped Intrauterine Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 T-shaped Intrauterine Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the T-shaped Intrauterine Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global T-shaped Intrauterine Device Market Size & Forecast, 2018-2028
4.5.1 T-shaped Intrauterine Device Market Size and Y-o-Y Growth
4.5.2 T-shaped Intrauterine Device Market Absolute $ Opportunity
Chapter 5 Global T-shaped Intrauterine Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 T-shaped Intrauterine Device Market Size Forecast by Type
5.2.1 Hormonal IUD
5.2.2 Copper IUD
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global T-shaped Intrauterine Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 T-shaped Intrauterine Device Market Size Forecast by Applications
6.2.1 Age 20-24
6.2.2 Age 25-34
6.2.3 Age 35-44
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global T-shaped Intrauterine Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 T-shaped Intrauterine Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America T-shaped Intrauterine Device Analysis and Forecast
9.1 Introduction
9.2 North America T-shaped Intrauterine Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America T-shaped Intrauterine Device Market Size Forecast by Type
9.6.1 Hormonal IUD
9.6.2 Copper IUD
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America T-shaped Intrauterine Device Market Size Forecast by Applications
9.10.1 Age 20-24
9.10.2 Age 25-34
9.10.3 Age 35-44
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe T-shaped Intrauterine Device Analysis and Forecast
10.1 Introduction
10.2 Europe T-shaped Intrauterine Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe T-shaped Intrauterine Device Market Size Forecast by Type
10.6.1 Hormonal IUD
10.6.2 Copper IUD
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe T-shaped Intrauterine Device Market Size Forecast by Applications
10.10.1 Age 20-24
10.10.2 Age 25-34
10.10.3 Age 35-44
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific T-shaped Intrauterine Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific T-shaped Intrauterine Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific T-shaped Intrauterine Device Market Size Forecast by Type
11.6.1 Hormonal IUD
11.6.2 Copper IUD
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific T-shaped Intrauterine Device Market Size Forecast by Applications
11.10.1 Age 20-24
11.10.2 Age 25-34
11.10.3 Age 35-44
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America T-shaped Intrauterine Device Analysis and Forecast
12.1 Introduction
12.2 Latin America T-shaped Intrauterine Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America T-shaped Intrauterine Device Market Size Forecast by Type
12.6.1 Hormonal IUD
12.6.2 Copper IUD
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America T-shaped Intrauterine Device Market Size Forecast by Applications
12.10.1 Age 20-24
12.10.2 Age 25-34
12.10.3 Age 35-44
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) T-shaped Intrauterine Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) T-shaped Intrauterine Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) T-shaped Intrauterine Device Market Size Forecast by Type
13.6.1 Hormonal IUD
13.6.2 Copper IUD
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) T-shaped Intrauterine Device Market Size Forecast by Applications
13.10.1 Age 20-24
13.10.2 Age 25-34
13.10.3 Age 35-44
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 T-shaped Intrauterine Device Market: Competitive Dashboard
14.2 Global T-shaped Intrauterine Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Merck
14.3.3 Teva Pharmaceutical
14.3.4 Allergan
14.3.5 HRA Pharma
14.3.6 Eurogine
14.3.7 Yantai JiShengYaoXie
14.3.8 TianYi
14.3.9 SMB Corporation
14.3.10 Shenyang Liren
14.3.11 H & J Medical
